Edward M. Kaye M.D., Director at Stoke Therapeutics, Inc. (STOK), sold 2,136 shares at $30.34 ($65K) on 2025-12-03, disclosed to the SEC on 2025-12-03.
Open-market sale of $65k STOK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.56 | 661 | $20K | 30.3% |
| 2 | $30.14 | 405 | $12K | 18.9% |
| 3 | $30.34 | 419 | $13K | 19.7% |
| 4 | $30.85 | 651 | $20K | 31.1% |
| Total | $30.22 avg | 2,136 | $65K | 100% |
| Filing → |
| STOK | SELL | 2025-12-10 | $702K | — | Filing → |
| STOK | SELL | 2025-12-05 | $879K | — | Filing → |
| CYTK | SELL | 2025-12-02 | $3.7M | — | Filing → |